tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Evolus launches Nuceiva neurotoxin in France through Symatese partnership

Evolus (EOLS) announced it has partnered with Symatese to commence distribution of Nuceiva, or botulinum toxin type A, in France. Nuceiva is approved by the European Commission for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows. Symatese, which has a direct presence in France, will be the exclusive distributor of Nuceiva in the country. This launch marks a milestone in Evolus’s commitment to strategic geographic expansion.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1